Roble, Belko & Company, Inc Davita Inc. Transaction History

Roble, Belko & Company, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$48.73 - $76.08 $61,935 - $96,697	-1,271 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$62.77 - $73.47 $14,499 - $16,971	-231 Reduced 15.38%	1,271 $88,000
Q1 2018 May 14, 2018	BUY	$65.0 - $80.03 $22,555 - $27,770	347 Added 30.04%	1,502 $99,000
Q4 2017 Jan 30, 2018	BUY	$53.89 - $72.36 $62,242 - $83,575	1,155	1,155 $83,000

663

74.4M

1.41M

1.82M

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $15.1B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Roble, Belko & Company, Inc with notifications on news.